Study of adverse events in patients treated with linezolid and vancomycin (Retrospective study)

Study of adverse events in patients treated with linezolid and vancomycin (Retrospective study) - Study of adverse events in patients treated with linezolid and vancomycin (Retrospective study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010759

Enrollment

300

Registered

2013-05-21

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial infections

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients treated with parenteral vancomycin or linezolid.

Exclusion criteria

Exclusion criteria: Patients had a treatment duration of less than 3 days, were discharged during treatment, or had missing clinical data. For the renal dysfunction aspect of the study, patients demonstrated end-stage renal failure or were undergoing hemodialysis. For the thrombocytopenia aspect of the study, patients developed disseminated intravascular coagulation or received a transfusion.

Design outcomes

Primary

Measure	Time frame
Occurrence rate of thrombocytopenia and renal dysfunction	—

Countries

Japan

Contacts

Public ContactSatoshi Fujii

Sapporo Medical University Hospital Department of Hospital Pharmacy

fujii.satoshi@sapmed.ac.jp

Outcome results